Show/Hide Menu
Hide/Show Apps
Logout
Türkçe
Türkçe
Search
Search
Login
Login
OpenMETU
OpenMETU
About
About
Open Science Policy
Open Science Policy
Open Access Guideline
Open Access Guideline
Postgraduate Thesis Guideline
Postgraduate Thesis Guideline
Communities & Collections
Communities & Collections
Help
Help
Frequently Asked Questions
Frequently Asked Questions
Guides
Guides
Thesis submission
Thesis submission
MS without thesis term project submission
MS without thesis term project submission
Publication submission with DOI
Publication submission with DOI
Publication submission
Publication submission
Supporting Information
Supporting Information
General Information
General Information
Copyright, Embargo and License
Copyright, Embargo and License
Contact us
Contact us
DESIGN AND CYTOTOXICITY ASSESSMENT OF FULLERENOL DERIVATIVES AS NEUROIMAGING PARTICLES AND CARRIER MOLECULES ACROSS THE BBB
Download
index.pdf
Date
2026-1-19
Author
Nursoy, Ahmet Zübeyir
Metadata
Show full item record
This work is licensed under a
Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License
.
Item Usage Stats
91
views
38
downloads
Cite This
After its discovery, fullerene became a point of interest in the scientific community. Its insolubility in water initially prevented its use in biomedical applications. Fortunately, studies revealed that surface modifications, such as hydroxylation (converting fullerenes into fullerenols), can help tackle this problem. Activation with <i>p</i>-nitrophenyl chloroformate enables covalent binding of molecules with free amino groups to fullerenols, thereby expanding their utility in biochemical applications. A molecule was designed to mimic the properties of the HIV-1 Tat protein (TAT), a lysine (K)- and arginine (R)-rich cell-penetrating peptide (CPP). Levodopa was incorporated for its antioxidant and neuroprotective properties, as well as its hypothesized ability to hinder amyloid-beta (Aβ) π–π stacking a critical step in amyloid fibrillization. These tailored modifications yielded a fullerenol-based nanoparticle with enhanced blood-brain barrier (BBB) penetration, functioning as a nanocarrier. At effective concentrations, designed molecules exhibited negligible cytotoxicity in cell line models and conferred cellular protection against oxidative stress induced by lead (II) acetate and Aβ<sub>1–42</sub>. One derivative demonstrated dual functionality: it interfered with Aβ fibrillation, suggesting potential as a non-invasive amyloidosis tracking agent (a hallmark of Alzheimer's Disease, AD), and it underwent conversion to neuromelanin <i>in vitro</i>, enabling MRI-based detection. This model molecule highlights the promise of multifunctional fullerenol-based systems as drug carriers, combining BBB penetrance, neuroprotection, and diagnostic capabilities.
Subject Keywords
Fullerenol
,
Neuroprotection
,
Nanocarrier
,
Cytotoxicity
,
Multifunctional nanoparticles
URI
https://hdl.handle.net/11511/118361
Collections
Graduate School of Natural and Applied Sciences, Thesis
Citation Formats
IEEE
ACM
APA
CHICAGO
MLA
BibTeX
A. Z. Nursoy, “DESIGN AND CYTOTOXICITY ASSESSMENT OF FULLERENOL DERIVATIVES AS NEUROIMAGING PARTICLES AND CARRIER MOLECULES ACROSS THE BBB,” M.S. - Master of Science, Middle East Technical University, 2026.